GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (OTCPK:NVYTF) » Definitions » EV-to-EBIT

NVYTF (Novacyt) EV-to-EBIT : -0.43 (As of Dec. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Novacyt EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Novacyt's Enterprise Value is $20.58 Mil. Novacyt's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-47.34 Mil. Therefore, Novacyt's EV-to-EBIT for today is -0.43.

The historical rank and industry rank for Novacyt's EV-to-EBIT or its related term are showing as below:

NVYTF' s EV-to-EBIT Range Over the Past 10 Years
Min: -210.21   Med: -2.8   Max: 10.28
Current: -0.43

During the past 13 years, the highest EV-to-EBIT of Novacyt was 10.28. The lowest was -210.21. And the median was -2.80.

NVYTF's EV-to-EBIT is ranked worse than
100% of 445 companies
in the Medical Devices & Instruments industry
Industry Median: 20.61 vs NVYTF: -0.43

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Novacyt's Enterprise Value for the quarter that ended in Jun. 2024 was $21.42 Mil. Novacyt's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-47.34 Mil. Novacyt's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -221.02%.


Novacyt EV-to-EBIT Historical Data

The historical data trend for Novacyt's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt EV-to-EBIT Chart

Novacyt Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.55 3.22 -29.42 0.54 -0.47

Novacyt Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.54 - -0.47 -

Competitive Comparison of Novacyt's EV-to-EBIT

For the Medical Devices subindustry, Novacyt's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novacyt's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Novacyt's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Novacyt's EV-to-EBIT falls into.



Novacyt EV-to-EBIT Calculation

Novacyt's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=20.583/-47.337
=-0.43

Novacyt's current Enterprise Value is $20.58 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novacyt's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-47.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novacyt  (OTCPK:NVYTF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Novacyt's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-47.337/21.417358
=-221.02 %

Novacyt's Enterprise Value for the quarter that ended in Jun. 2024 was $21.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novacyt's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-47.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novacyt EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Novacyt's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Novacyt Business Description

Traded in Other Exchanges
Address
13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, IT-IS International, Lab21 Products, Corporate, Yourgene Health and Intercompany eliminations. Majority of the revenue is generated from Yourgene Health segment.

Novacyt Headlines